cor2ed
engage checkpoint medical linkedin twitter
bg

SIRT or sorafenib in patients with locally advanced HCC: SARAH and SIRveNIB trials

SIRT or sorafenib in patients with locally advanced HCC: SARAH and SIRveNIB trials

Dr. Mohamed Bouattour

Dr. Mohamed Bouattour from Hôpital Beaujon, APHP Clichy, France, discusses the SARAH and SIRveNIB trials in locally advanced HCC
Portrait of Mohamed Bouattour
Dr. Mohamed Bouattour

Hepatologist and Gastroenterologist

Beaujon University Hospital

France

preview next

time Expert View | open 5 min

download resources

I agree that this educational programme:

Was valuable to me:

1/3

Other programmes of interest